Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Boehringer Ingelheim (Japan)

InstitutionResearch output, impact & collaborations

Boehringer Ingelheim (Japan) is a institution indexed in PICO Portal from OpenAlex.

What is known about Boehringer Ingelheim (Japan)?

PICO Portalrecord summary

Boehringer Ingelheim (Japan) is a research organisation in Tokyo, JP. OpenAlex records 1,025 works and 87,040 citations for it. 296 researchers list it as their most recent affiliation.

How many works does Boehringer Ingelheim (Japan) have?

PICO Portalindexed works

Boehringer Ingelheim (Japan) has 1,025 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Boehringer Ingelheim (Japan) have?

PICO Portalcitation count

Boehringer Ingelheim (Japan) has 87,040 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Boehringer Ingelheim (Japan)?

PICO Portalresearcher count

Boehringer Ingelheim (Japan) has 296 researchers in the PICO Portal index.

What is the average h-index at Boehringer Ingelheim (Japan)?

PICO Portalavg h-index

Boehringer Ingelheim (Japan) has an average h-index of 2 in OpenAlex.

What is the ROR of Boehringer Ingelheim (Japan)?

PICO Portalror

The ROR for Boehringer Ingelheim (Japan) is on the source record.

What is the OpenAlex record for Boehringer Ingelheim (Japan)?

PICO Portalopenalex

The OpenAlex for Boehringer Ingelheim (Japan) is on the source record.

Who are the most-cited researchers behind Boehringer Ingelheim (Japan)?

PICO Portaltop researchers by citations
1
Satabdi Chatterjee · Chronic Kidney Disease and Diabetes
11 works43 citations

What are the most-cited papers on Boehringer Ingelheim (Japan)?

PICO Portalmost cited works
The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio–Renal–Metabolic Syndrome
Gregory A. Nichols, Efrat L. Amitay, Satabdi Chatterjee, Dominik Steubl
Metabolic Syndrome and Related Disorders. 202327 Citations
Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases
Gregory A. Nichols, Efrat L. Amitay, Satabdi Chatterjee, Dominik Steubl
Kidney360. 202316 CitationsOPEN ACCESS
HSD80 Evaluation of Methotrexate Based Combinations in Rheumatoid Arthritis Patients: Results from a U.S. Administrative Claims Database
Yuying Huang, Shreya Agarwal, H Chen, Magnus L. Johnson, Satabdi Chatterjee, RR Aparasu
Value in Health. 20220 CitationsOPEN ACCESS
HSD133 Factors Influencing Selection of First Add-on Disease-Modifying Therapy for Rheumatoid Arthritis after Starting Methotrexate
Yixuan Huang, Suneal Agarwal, H Chen, Magnus L. Johnson, Satabdi Chatterjee, RR Aparasu
Value in Health. 20220 Citations
The Effect of Cardiometabolic Comorbidities on Risk of Chronic Kidney Disease Incidence: A Longitudinal Cohort Study
Gregory A. Nichols, Moe H. Kyaw, Satabdi Chatterjee, Dominik Steubl, Assad Jaghutriz Benjamin
Diabetologie und Stoffwechsel. 20220 Citations

How much of the research on Boehringer Ingelheim (Japan) is open access?

PICO Portalopen access share
40%OPEN ACCESS
Gold
30%
Green
0%
Hybrid
0%
Bronze
10%
Closed
60%

Related on PICO Portal

470M+ articles · 14-day free trial